The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation

Abstract Background SND1 participates in tumorigenesis, tumour invasion and metastasis in different cancers. Previous studies have shown that SND1 can promote the invasion and migration of breast cancer cells. Triple-negative breast cancer (TNBC) is a specific breast cancer subtype with high metasta...

Full description

Bibliographic Details
Main Authors: Huibian Zhang, Min Gao, Wenying Zhao, Lin Yu
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Breast Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13058-023-01731-3
_version_ 1797647152282861568
author Huibian Zhang
Min Gao
Wenying Zhao
Lin Yu
author_facet Huibian Zhang
Min Gao
Wenying Zhao
Lin Yu
author_sort Huibian Zhang
collection DOAJ
description Abstract Background SND1 participates in tumorigenesis, tumour invasion and metastasis in different cancers. Previous studies have shown that SND1 can promote the invasion and migration of breast cancer cells. Triple-negative breast cancer (TNBC) is a specific breast cancer subtype with high metastatic potential and poor prognosis. However, the specific roles and mechanisms of SND1 in TNBC metastasis remain unaddressed. Methods Immunostaining was used to detect the SND1 expression in tissue samples of 58 TNBC and 10 glioblastomas (GBM) as positive control. The correlation between SND1 expression and patient prognosis was assessed using the Kaplan–Meier estimator. The gene expression was evaluated by qRT-PCR, Western blot and immunofluorescence analyses. Gene Ontology analysis, ChIP, a dual-luciferase reporter assay, EMSA, and 3C analysis were applied to identify SND1-activated target genes. Bisulfite sequencing PCR and MeDIP were used to detect DNA methylation. We also used wound healing, Transwell and orthotopic implantation assays to investigate the function of SND1 in TNBC cell migration and invasion. Results The data of immunohistochemistry manifested that SND1 is the overexpression in metastasized TNBC and an independent factor for TNBC prognosis. SND1 knockdown inhibited the migration and invasion of TNBC cells. We found that SND1 promotes the metastatic phenotype of TNBC cells by epigenetically altering chromatin conformational interactions, which in turn activates DNMT3A transcription. Then, DNMT3A attenuates CCND1 expression by inducing CCND1 gene methylation, leading to TNBC metastasis. Conclusion SND1 can promote the invasion and migration of TNBC cells by promoting DNMT3A expression and suppressing CDH1 activity. SND1 is a potential biomarker and a promising therapeutic target for TNBC.
first_indexed 2024-03-11T15:13:11Z
format Article
id doaj.art-e1af911b90244c41a4f682104d352508
institution Directory Open Access Journal
issn 1465-542X
language English
last_indexed 2024-03-11T15:13:11Z
publishDate 2023-10-01
publisher BMC
record_format Article
series Breast Cancer Research
spelling doaj.art-e1af911b90244c41a4f682104d3525082023-10-29T12:40:53ZengBMCBreast Cancer Research1465-542X2023-10-0125111710.1186/s13058-023-01731-3The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylationHuibian Zhang0Min Gao1Wenying Zhao2Lin Yu3Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical UniversityAbstract Background SND1 participates in tumorigenesis, tumour invasion and metastasis in different cancers. Previous studies have shown that SND1 can promote the invasion and migration of breast cancer cells. Triple-negative breast cancer (TNBC) is a specific breast cancer subtype with high metastatic potential and poor prognosis. However, the specific roles and mechanisms of SND1 in TNBC metastasis remain unaddressed. Methods Immunostaining was used to detect the SND1 expression in tissue samples of 58 TNBC and 10 glioblastomas (GBM) as positive control. The correlation between SND1 expression and patient prognosis was assessed using the Kaplan–Meier estimator. The gene expression was evaluated by qRT-PCR, Western blot and immunofluorescence analyses. Gene Ontology analysis, ChIP, a dual-luciferase reporter assay, EMSA, and 3C analysis were applied to identify SND1-activated target genes. Bisulfite sequencing PCR and MeDIP were used to detect DNA methylation. We also used wound healing, Transwell and orthotopic implantation assays to investigate the function of SND1 in TNBC cell migration and invasion. Results The data of immunohistochemistry manifested that SND1 is the overexpression in metastasized TNBC and an independent factor for TNBC prognosis. SND1 knockdown inhibited the migration and invasion of TNBC cells. We found that SND1 promotes the metastatic phenotype of TNBC cells by epigenetically altering chromatin conformational interactions, which in turn activates DNMT3A transcription. Then, DNMT3A attenuates CCND1 expression by inducing CCND1 gene methylation, leading to TNBC metastasis. Conclusion SND1 can promote the invasion and migration of TNBC cells by promoting DNMT3A expression and suppressing CDH1 activity. SND1 is a potential biomarker and a promising therapeutic target for TNBC.https://doi.org/10.1186/s13058-023-01731-3SND1Triple-negative breast cancerChromatin architectural interactionMetastasis
spellingShingle Huibian Zhang
Min Gao
Wenying Zhao
Lin Yu
The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation
Breast Cancer Research
SND1
Triple-negative breast cancer
Chromatin architectural interaction
Metastasis
title The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation
title_full The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation
title_fullStr The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation
title_full_unstemmed The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation
title_short The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation
title_sort chromatin architectural regulator snd1 mediates metastasis in triple negative breast cancer by promoting cdh1 gene methylation
topic SND1
Triple-negative breast cancer
Chromatin architectural interaction
Metastasis
url https://doi.org/10.1186/s13058-023-01731-3
work_keys_str_mv AT huibianzhang thechromatinarchitecturalregulatorsnd1mediatesmetastasisintriplenegativebreastcancerbypromotingcdh1genemethylation
AT mingao thechromatinarchitecturalregulatorsnd1mediatesmetastasisintriplenegativebreastcancerbypromotingcdh1genemethylation
AT wenyingzhao thechromatinarchitecturalregulatorsnd1mediatesmetastasisintriplenegativebreastcancerbypromotingcdh1genemethylation
AT linyu thechromatinarchitecturalregulatorsnd1mediatesmetastasisintriplenegativebreastcancerbypromotingcdh1genemethylation
AT huibianzhang chromatinarchitecturalregulatorsnd1mediatesmetastasisintriplenegativebreastcancerbypromotingcdh1genemethylation
AT mingao chromatinarchitecturalregulatorsnd1mediatesmetastasisintriplenegativebreastcancerbypromotingcdh1genemethylation
AT wenyingzhao chromatinarchitecturalregulatorsnd1mediatesmetastasisintriplenegativebreastcancerbypromotingcdh1genemethylation
AT linyu chromatinarchitecturalregulatorsnd1mediatesmetastasisintriplenegativebreastcancerbypromotingcdh1genemethylation